FDA Warning Letter Explorer
Drugs · Sep 9, 2025

Get.Fit.Medical, LLC dba Get.Fit.Medical

1 extracted findings · 1 model-assigned issue type

FDA source excerpt, selected passage

your website offers various compounded drug products, including sildenafil, tadalafil, semaglutide, and tirzepatide.

Findings and supporting evidence

Model-assisted readings, not an exhaustive interpretation. Compare with the extracted source findings below.

Labeling, claims & marketing

The website offers compounded drug products with claims that imply they are the same as FDA-approved products, which is false and misleading.

Supporting FDA text
Source excerpt · automated text-match check

your website offers various compounded drug products, including sildenafil, tadalafil, semaglutide, and tirzepatide.

Findings extracted from the letter

Selected FDA passages, not the complete letter.

01
your website offers various compounded drug products, including sildenafil, tadalafil, semaglutide, and tirzepatide.

Source passage selected by the model

What FDA requested

Model-assisted summary. Consult the letter for complete requests and conditions.

  • Provide a written response describing the specific steps taken to address the violations, including an explanation of each step taken to prevent recurrence, and copies of related documentation.
Keep exploring

More drug letters

Recent records for the same product type. Your previous filters remain available when you return.

Keep exploring

For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.